Paper32905276
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
Roy S and 7 others. ACS Omega, 2020. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer. Papers, record 32905276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22684547 | Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. | Int J Colorectal Dis | 2012 | https://conductscience.org/library/papers/22684547 | PubMed |
| 2 | 25153718 | SPHK1 regulates proliferation and survival responses in triple-negative breast cancer. | Oncotarget | 2014 | https://conductscience.org/library/papers/25153718 | PubMed |
| 3 | 12011102 | Sphingosine 1-phosphate, a key cell signaling molecule. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12011102 | PubMed |
| 4 | 22801037 | Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/22801037 | PubMed |
| 5 | 3036349 | Vinca alkaloids in the treatment of non-small cell lung cancer. | Cancer Treat Rev | 1987 | https://conductscience.org/library/papers/3036349 | PubMed |
| 6 | 15623571 | Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. | J Exp Med | 2005 | https://conductscience.org/library/papers/15623571 | PubMed |
| 7 | 25529771 | Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway. | Oncol Rep | 2015 | https://conductscience.org/library/papers/25529771 | PubMed |
| 8 | 30575912 | LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. | Eur Rev Med Pharmacol Sci | 2018 | https://conductscience.org/library/papers/30575912 | PubMed |
| 9 | 12970760 | Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12970760 | PubMed |
| 10 | 12527563 | Epidemiology of lung cancer. | Chest | 2003 | https://conductscience.org/library/papers/12527563 | PubMed |
| 11 | 20041830 | Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. | Drug Metab Lett | 2009 | https://conductscience.org/library/papers/20041830 | PubMed |
| 12 | 30678498 | Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/30678498 | PubMed |
| 13 | 29434892 | Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29434892 | PubMed |
| 14 | 29208982 | Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo. | Sci Rep | 2017 | https://conductscience.org/library/papers/29208982 | PubMed |
| 15 | 3703465 | Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs. | Oncology | 1986 | https://conductscience.org/library/papers/3703465 | PubMed |
| 16 | 2890483 | Inhibition of Na+-Ca2+ exchange mechanism in cardiac sarcolemmal vesicles by harmaline. | Comp Biochem Physiol C Comp Pharmacol Toxicol | 1987 | https://conductscience.org/library/papers/2890483 | PubMed |
| 17 | 7491124 | Genotoxic potential of beta-carbolines: a review. | Mutat Res | 1995 | https://conductscience.org/library/papers/7491124 | PubMed |
| 18 | 28352583 | Peganum harmala L.'s anti-growth effect on a breast cancer cell line. | Biotechnol Rep (Amst) | 2015 | https://conductscience.org/library/papers/28352583 | PubMed |
| 19 | 25516793 | Crystal Structure of Sphingosine Kinase 1 with PF-543. | ACS Med Chem Lett | 2014 | https://conductscience.org/library/papers/25516793 | PubMed |
| 20 | 28744400 | Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat. | Am J Cancer Res | 2017 | https://conductscience.org/library/papers/28744400 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42640499 | The potential of harmaline on triple negative breast cancer: harmaline-DNA interaction related apoptosis, anti-metastasis, and in silico analysis. | Histochem Cell Biol | 2026 | https://conductscience.org/library/papers/42640499 | PubMed |
| 42417936 | Harmaline and the gut-brain-immune axis: a novel therapeutic avenue in neuroinflammation and ulcerative colitis. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42417936 | PubMed |
| 41221048 | Molecular docking and dynamics in protein serine/threonine kinase drug discovery: advances, challenges, and future perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41221048 | PubMed |
| 41088942 | Targeting Chemical-induced Hepatocellular Carcinoma: Ameliorative Potential of Natural Compounds with Focus on Beta-carbolines. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41088942 | PubMed |
| 40453822 | Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40453822 | PubMed |
| 39766081 | Serum Metabolomics Study to Screen Potential Biomarkers of Lung Cancer Risk in High Natural Background Radiation Areas of Thailand: A Pilot Study. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39766081 | PubMed |
| 38931386 | The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931386 | PubMed |
| 38829482 | Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/38829482 | PubMed |
| 38531560 | Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro. | Physiol Rep | 2024 | https://conductscience.org/library/papers/38531560 | PubMed |
| 38276008 | Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38276008 | PubMed |
| 38234667 | In vitro pro-apoptotic and anti-metastatic potentials of harmaline-silver containing folate-linked chitosan nano-drug delivery system. | Iran J Basic Med Sci | 2024 | https://conductscience.org/library/papers/38234667 | PubMed |
| 36943605 | Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/36943605 | PubMed |
| 36709362 | Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses. | Sci Rep | 2023 | https://conductscience.org/library/papers/36709362 | PubMed |
| 36402936 | Photosensitizing properties and subcellular localisation of 3,4-dihydro-β-carbolines harmaline and harmalol. | Photochem Photobiol Sci | 2023 | https://conductscience.org/library/papers/36402936 | PubMed |
| 35799611 | Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target. | J Oncol | 2022 | https://conductscience.org/library/papers/35799611 | PubMed |
| 35720007 | Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing. | Front Oncol | 2022 | https://conductscience.org/library/papers/35720007 | PubMed |
| 35630821 | Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells. | Molecules | 2022 | https://conductscience.org/library/papers/35630821 | PubMed |
| 35216066 | Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216066 | PubMed |
| 34885979 | Structural Characterization of Ectodomain G Protein of Respiratory Syncytial Virus and Its Interaction with Heparan Sulfate: Multi-Spectroscopic and In Silico Studies Elucidating Host-Pathogen Interactions. | Molecules | 2021 | https://conductscience.org/library/papers/34885979 | PubMed |
| 34737701 | Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34737701 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CYP1A1 | 1543 | PubTator's text mining | https://conductscience.org/library/genes/1543 | NCBI Gene |
| DNAH8 | 1769 | PubTator's text mining | https://conductscience.org/library/genes/1769 | NCBI Gene |
| HNMT | 3176 | PubTator's text mining | https://conductscience.org/library/genes/3176 | NCBI Gene |
| S1PR1 | 1901 | PubTator's text mining | https://conductscience.org/library/genes/1901 | NCBI Gene |
| S1PR5 | 53637 | PubTator's text mining | https://conductscience.org/library/genes/53637 | NCBI Gene |
| SPHK1 | 8877 | PubTator's text mining | https://conductscience.org/library/genes/8877 | NCBI Gene |
| SPHK2 | 56848 | PubTator's text mining | https://conductscience.org/library/genes/56848 | NCBI Gene |
| TRAF2 | 7186 | PubTator's text mining | https://conductscience.org/library/genes/7186 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32905276
GET https://conductscience.org/api/papers/v1/32905276/references?page=2